Education
About Us
Working with TipRanks
Follow Us
Chiome Bioscience Inc. (JP:4583)
:4583
4583 Stock Chart & Stats
¥108.00
-¥13.00(-4.94%)
At close: 4:00 PM EST
¥108.00
-¥13.00(-4.94%)
Day’s Range― - ―
52-Week Range¥106.00 - ¥294.00
Previous CloseN/A
Volume5.12M
Average Volume (3M)521.30K
Market Cap
¥7.35B
Enterprise Value¥8.91B
Total Cash (Recent Filing)¥1.47B
Total Debt (Recent Filing)¥260.50M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.82
Shares Outstanding68,053,800
10 Day Avg. Volume796,530
30 Day Avg. Volume521,303
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)8.15
Price to Sales (P/S)20.05
P/FCF Ratio-15.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Chiome Bioscience Inc. News
4583 FAQ
What was Chiome Bioscience Inc.’s price range in the past 12 months?
Chiome Bioscience Inc. lowest stock price was ¥106.00 and its highest was ¥294.00 in the past 12 months.
What is Chiome Bioscience Inc.’s market cap?
Chiome Bioscience Inc.’s market cap is ¥7.35B.
When is Chiome Bioscience Inc.’s upcoming earnings report date?
Chiome Bioscience Inc.’s upcoming earnings report date is May 20, 2026 which is in 152 days.
How were Chiome Bioscience Inc.’s earnings last quarter?
Chiome Bioscience Inc. released its earnings results on Nov 11, 2025. The company reported -¥3.82 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.82.
Is Chiome Bioscience Inc. overvalued?
According to Wall Street analysts Chiome Bioscience Inc.’s price is currently Overvalued.
Does Chiome Bioscience Inc. pay dividends?
Chiome Bioscience Inc. does not currently pay dividends.
What is Chiome Bioscience Inc.’s EPS estimate?
Chiome Bioscience Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chiome Bioscience Inc. have?
Chiome Bioscience Inc. has 68,053,800 shares outstanding.
What happened to Chiome Bioscience Inc.’s price movement after its last earnings report?
Chiome Bioscience Inc. reported an EPS of -¥3.82 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.504%.
Which hedge fund is a major shareholder of Chiome Bioscience Inc.?
Currently, no hedge funds are holding shares in JP:4583
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Chiome Bioscience Inc.
Chiome Bioscience Inc. (4583) is a biotechnology company focused on the research, development, and commercialization of therapeutic antibodies. Operating in the pharmaceutical and healthcare sectors, the company leverages its proprietary ADLib system technology to discover novel antibody candidates for various diseases, including cancer and inflammatory conditions. Chiome Bioscience aims to address unmet medical needs by developing innovative antibody-based therapies.
Technical Analysis
NanoCarrier Co., Ltd.
―
MEDINET Co., Ltd.
―
Kidswell Bio Corporation
―
Oncolys BioPharma, Inc.
―
Noile-Immune Biotech Inc.
―